Alzheimer’s Disease and Other Dementias in China: Secular Trend in Disease Burden from 1990 to 2019 and Projections to 2030
Jiawei Geng,Therese Hesketh
DOI: https://doi.org/10.1002/alz.062694
2023-01-01
Abstract:AbstractBackgroundAlzheimer’s disease and other dementias (ADOD) inflict substantial burden on the individual, family and society. China has the world’s highest number of people living with dementia, but the national‐level secular trends have not been well‐characterized.MethodDrawing on data from the Global Burden of Disease Study 2019, we explored the burden of ADOD in China from 1990 to 2019, including its prevalence, incidence, mortality, years of lost (YLLs), years of life lived with disability (YLDs), disability adjusted life years (DALYs), and attributable specific risk factors. Temporal trends in disease burden were calculated by average annual percentage changes (AAPCs) using log‐linear regression in age‐standardized rates. We utilized Bayesian age‐period‐cohort models with integrated nested Laplace approximations to predict the age‐sex‐specific number of new cases and deaths from 2020 to 2030.ResultThe age‐standardized prevalence, incidence, deaths, YLLs, YLDs and DALYs for ADOD were 788.28, 103.83, 23.32, 254.42, 114.07 and 368.49 per 100,000 population in 2019 respectively, with increasing trends observed (AAPC [95% Confidence Interval]: 0.66% [0.57 to 0.75], 0.33% [0.27 to 0.40], 0.15% [0.07 to 0.23], 0.10% [0.01 to 0.20], 0.65% [0.56 to 0.75], and 0.26% [0.21 to 0.31]) during the past three decades. Although ADOD is more prevalent in females, AAPCs in all indicators were more pronounced in males. More dementia cases were attributable to smoking in males than in females. Proportions of DALYs attributable to high BMI increased over time in both sexes, and the cases attributable to high fasting glucose were comparable in both sexes. Incidence and mortality from ADOD are projected to be 2,967,059 and 527,960 cases in 2030, representing a 1.65‐fold increase.ConclusionIncreasing incidence and mortality due to ADOD will continue in coming years due to population aging, although age‐standardized mortality rates showed a slight decrease. Further research on modifiable risk factors and targeted prevention strategies are warranted.